SNWV Stock Analysis: Buy, Sell, or Hold?
SNWV - SANUWAVE Health, Inc. Common Stock
$15.57
-1.08 (-6.49%)
▼
5d:
-1.02%
30d:
-14.26%
90d:
-39.72%
HOLD
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 13, 2026
2d
Get Alerted When SNWV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNWV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SNWV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$46.49
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$28.87
46.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNWV is currently trading at $15.57, which is considered oversold relative to its 30-day fair value range of $16.16 to $18.88. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.3) compared to its historical average (25.9). Remarkably, the market is currently pricing in an annual earnings decline of 14.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $15.36. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: SNWV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $43.50 (+179.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $15.36. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: SNWV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $43.50 (+179.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$16.16 -
$18.88
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.5%)
- BULLISH: Trading 179.4% below Wall St target ($43.50)
Trading Range Analysis
30-Day Trading Range
$16.16 -
$18.88
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$15.36
Resistance Level
$19.33
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.30
Wall Street Target
$43.50
(+179.4%)
Revenue Growth (YoY)
26.8%
Earnings Growth (YoY)
-99.6%
Profit Margin
26.8%
Valuation Discount vs History
-14.3% cheaper
PE vs Historical
16.3 vs 25.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.3%
(market-implied from PE analysis)
1-Year Target
$14.01
(-10%)
2-Year Target
$12.61
(-19%)
3-Year Target
$11.35
(-27%)
3-Yr Target (if PE normalizes)
(PE: 16→26)
$18.03
(+16%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 148.1%)
$70.72
(+354%)
Base:
(SPY PE: 16.3, Growth: 148.1%)
$52.55
(+238%)
Bear:
(PE: 13.9, Growth: 148.1%)
$44.67
(+187%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (41x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 40.61 | Current EPS (TTM): $0.41
Bull Case
$36.63
(+135%)
Analyst growth 100.0%, PE expands to 44.7
Base Case
$33.30
(+114%)
Market implied 100.0%, PE stable at 40.6
Bear Case
$11.32
(-27%)
Severe decline -20.0%, PE contracts to 34.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.3 to 25.9
Stabilization Target:
$24.73
(+58.9%)
PE Expansion Potential:
+58.9%
Share & Embed Analysis
Last updated: May 09, 2026 10:21 PM ET
Data refreshes hourly during market hours. Next update: 11:21 PM
Data refreshes hourly during market hours. Next update: 11:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNWV showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$394 | 53 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$326 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 56 HOLD |
